In a conversation with Pharmaceutical Executive, Morten Graugaard, CEO, Orbis Medicines, discussed FDA’s approval of Icotyde ...
The firm will deliver SGT-212 to patients' brains and intravenously to try to restore frataxin levels and diminish ...
14d
BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries
VANCOUVER, BC / ACCESS Newswire / April 7, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
The European panel has expanded delivery options for multiple myeloma by approving a subcutaneous (SC) option for a key anti‑CD38 myeloma therapy. At its March 2026 meeting, the European Medicines ...
Virginia Allen is a senior news producer for The Daily Signal and host of "The Daily Signal Podcast" and "Problematic Women." Send an email to Virginia. Faith is a central part of the Trump ...
Eli Lilly is close to launching its own oral anti-obesity medicine, orforglipron. This new therapy could be better than oral Wegovy and allow Lilly to remain the weight-loss leader. While oral Wegovy ...
Feb 25 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab has partnered with U.S.-based Vivtex Corp in a deal worth up to $2.1 billion to develop next-generation oral drugs for ...
The intestinal wall is like a gatekeeper, absorbing certain compounds while keeping others from passing through. To the medical field, the gastrointestinal tract is more like a black box, said Thomas ...
Following the launch of its Wegovy (semaglutide) pill at the beginning of the year, Novo Nordisk is committing as much as $2.1 billion to next-gen delivery mechanisms for its metabolic portfolio. The ...
Novo Nordisk announced Wednesday a collaboration with startup Vivtex that’ll give it access to technologies that could yield new oral biologics for obesity and other metabolic diseases. The companies ...
Coming off a U.S. FDA approval of the first GLP-1 in pill format, Novo Nordisk A/S leaned further into oral drug delivery efforts, partnering with Vivtex Corp. to develop next-generation oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results